Chapter 940： Pricing (Part 1) (1/2)

Chapter 935 Pricing (Part 1)

Zhang Guoqing solemnly nodded his head: ”Boss, don't worry, the preparations have already been made and have been waiting for the approval of the approval.”

Of course, Xingchen Pharmaceutical is a law-abiding enterprise. Before it has a real drug production qualification certificate, Xingchen Pharmaceutical will not actually produce general cancer treatment drugs, but it does not hinder the preparation of raw materials for production.

The expanded production line was also ready in this month.

Just wait for an order and start working with all strength.

In fact, energy spar is still the most lacking, as long as there is enough energy spar, drug production is not a problem.

Liu Mingyu knows that Xingchen Pharmaceutical has always been ready for production through Xingchen Materials. Now that he hears Zhang Guoqing's confirmation, he is more relieved.

Suddenly, I thought of a more important question, and asked: ”What is the price of the general cancer treatment?”

To put it in a thousand words, pricing is a big problem after the drug is on the market.

To be honest, some people are willing to buy special medicines like Xingchen Pharmaceuticals that cure all cancers, even if they are no problem at the late stage.

This is a real life-saving medicine that can save a life, no matter how expensive it is, someone will accept it.

Generally speaking, there are two methods for pricing new drugs.

First, the government will reasonably customize and adjust prices based on the price law, average social cost, market supply and demand, and social affordability.

Second, for drugs regulated by the market, pharmaceutical companies set prices in accordance with the production cost and the principles of fairness, reasonableness, and integrity.

The general cancer treatment is a product of Xingchen Pharmaceutical, and naturally belongs to the second type, which is priced by Xingchen Pharmaceutical.

Of course, this kind of pricing cannot be too outrageous, there is always a basis.

In fact, the production of raw materials for most drugs is not very high, but the research and development costs are very high. This part of the research and development costs will also be shared by the pharmaceutical companies in each drug, and the pharmaceutical companies will carry out Apportion accordingly.

Therefore, I can often see that medicines that are only a few cents, or even a few cents, are sold for a few yuan, even a dozen yuan.

This includes research and development costs.

Zhang Guoqing is not very clear about the research and development costs of general cancer drugs. This information is provided directly by the boss in front of him.

If you only calculate the cost of Hou Yaolin's start of research and development, it is quite low.

The real pricing is of course impossible to price like this. Zhang Guoqing finally threw the pricing problem back to Liu Mingyu.

”Boss, I don't know the cost of this research and development. What price is more appropriate?”

Generic medicine for cancer treatment is a derivative of the genetic evolution potion, but it does not mean that there is no research and development cost, and a reasonable price needs to be set.

In fact, Liu Mingyu also knows that according to the efficacy of general cancer treatment drugs, even if the price is expensive, some people will pay the bill. This is a monopoly product.

Liu Mingyu didn't want to set too high a price so that the common people could not use the price, but if the price was too cheap, it wouldn't work, because too many people would buy medicines and sell them to other people at high prices to become a medicine scalper.

This is definitely not an exaggeration. Drug reselling is something that is often seen in society, especially in primary clinics.

The general drug for cancer treatment is on the market and will definitely be targeted by scalpers.

In this way, no matter what Liu Mingyu's price is, it will ultimately be the people who really need the generic cancer treatment.